LoPresto Jennifer Hayes 4

What Happened

• Jennifer Hayes LoPresto, Senior Vice President of HealthStream, was granted 2,183 restricted stock units (RSUs) on March 18, 2026. The award is reported as an acquisition of a derivative security at a $0 purchase price — typical for equity awards. RSUs are not immediate shares; they represent the contingent right to receive one share of common stock upon vesting.

Key Details

• Transaction date: March 18, 2026; Form 4 filed March 24, 2026 (appears to be filed after the usual 2-business-day window).
• Grant size: 2,183 RSUs; reported acquisition price: $0.00 (derivative award).
• Shares owned after transaction: Not reported in this filing.
• Footnotes of note:
  • F1: Each RSU converts to one share upon vesting.
  • F2: Vesting schedule — 15% on 3/18/2027; 20% on 3/18/2028; 30% on 3/18/2029; 35% on 3/18/2030 (contingent on continued service).
  • F3: Not applicable (no special tax-withholding or other adjustment noted).
• Filing timeliness: The Form 4 was filed six days after the grant date; Form 4 disclosures are generally due within two business days of the reportable transaction, so this appears late and may warrant attention by regulators or investors monitoring timely disclosure.

Context

• RSU grants are compensation awards that vest over time and do not reflect an immediate cash purchase or sale. They become economically meaningful only as they vest and convert to shares (or are settled in cash, if applicable).
• Because this is a grant (not a market purchase), it should be viewed primarily as compensation/retention rather than an indicator of the insider buying or selling stock for personal investment purposes.